文献速递肿瘤 PET/CT放射性药物与辐射防护

PET/MR在儿童组织细胞增生症评估中的应用:与PET/CT的比较

PET/MR in the Assessment of Pediatric Histiocytoses: A Comparison to PET/CT.
PubMed 文献 · Clin Nucl Med · 2017-01-01

该前瞻性研究纳入9例儿童组织细胞增生症患者(平均年龄6.2岁),共完成17次单次注射双模态显像的PET/CT与PET/MR检查,比较图像质量、病灶检出和FDG定量。所有PET/MR图像质量良好或优秀且临床可接受,按患者分析两种模态对活动性疾病识别完全一致,PET/MR正确分类了PET/CT所识别77个病灶中的74个(96%),病灶最大SUV两种模态高度相关(Spearman相关系数0.73,P<0.001)。作者认为PET/MR在儿童组织细胞疾病中临床可行,图像质量与病灶检出和PET/CT相当,且因显著减少辐射剂量而成为有吸引力的替代选择。

要点

  • 9例患儿共17次检查,PET/MR图像质量均为良好或优秀且临床可接受。
  • 按患者分析,PET/MR与PET/CT对活动性疾病的识别完全一致。
  • PET/MR正确分类PET/CT所识别77个病灶中的74个(96%),病灶最大SUV高度相关(Spearman相关系数0.73,P<0.001)。

核心结论

  • PET/MR在儿童组织细胞疾病患者中临床可行,图像质量与病灶检出和PET/CT相当,定量性能高度相关。
  • 鉴于显著减少辐射剂量,作者认为PET/MR是儿童组织细胞疾病诊疗中有吸引力的PET/CT替代选择。

研究设计与样本

  • 前瞻性研究,纳入诊断为朗格汉斯细胞组织细胞增生症或罗萨伊-多尔夫曼病的儿童。
  • 9例患者(平均年龄6.2岁)按单次注射双模态显像方案完成17次PET/CT与PET/MR检查。
  • 检查指征为朗格汉斯细胞组织细胞增生症10次、罗萨伊-多尔夫曼病7次。
  • 对匿名数据评估图像质量与病灶检出,并对每个病灶比较两种模态的SUV定量。

主要发现

  • 所有PET/MR检查图像质量均为良好或优秀,且被认为临床可接受。
  • PET/MR图像阅片者之间对PET图像质量有高度一致性。
  • 按患者分析,PET/MR与PET/CT对活动性疾病的识别完全一致。
  • PET/MR正确分类了PET/CT所识别77个病灶中的74个(96%)。
  • 病灶最大SUV在两种模态间高度相关,Spearman相关系数为0.73(P<0.001)。

临床怎么用

  • 作者认为,鉴于显著减少辐射剂量,PET/MR是儿童组织细胞疾病诊疗中有吸引力的PET/CT替代选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aim of this study was to analyze the feasibility and diagnostic performance of F-FDG PET/MR compared with F-FDG PET/CT in a cohort of pediatric histiocytosis patients with regard to image quality, lesion detection, and FDG quantification. METHODS: Children with a diagnosis of Langerhans cell histiocytosis or Rosai-Dorfman disease were prospectively recruited. Seventeen PET/CT and PET/MR examinations were performed on 9 patients (mean age, 6.2 years) following a single-injection dual-imaging protocol. The indication was Langerhans cell histiocytosis in 10 examinations and Rosai-Dorfman disease in 7 examinations. The anonymized data were evaluated for image quality and lesion detection. SUV quantification of each lesion was compared between modalities. RESULTS: All PET/MR examinations had good or excellent image quality and were deemed clinically acceptable. There was substantial agreement of PET image quality among readers of PET/MR images. Per patient, PET/MR and PET/CT had complete concordance in identifying active disease. PET/MRI correctly classified 74 (96%) of 77 foci of disease identified on PET/CT. The per-lesion maximum SUVs were strongly correlated between modalities with a Spearman correlation coefficient of 0.73 (P < 0.001). CONCLUSIONS: The use of PET/MR is clinically feasible in pediatric patients with a histiocytic disease. PET/MR demonstrates comparable image quality and lesion detection to PET/CT while maintaining strongly correlated quantitative performance. Given the significant radiation dose savings, PET/MR represents an appealing alternative to PET/CT in the care of children with histiocytic disorders.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Sher AC, Orth R, McClain K, et al. PET/MR in the Assessment of Pediatric Histiocytoses: A Comparison to PET/CT. Clin Nucl Med. 2017. PMID: 28604476. doi:10.1097/RLU.0000000000001717

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。